Haemonetics Total Assets 2006-2019 | HAE

Haemonetics total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Haemonetics total assets for the quarter ending June 30, 2019 were $1.260B, a 1.49% increase year-over-year.
  • Haemonetics total assets for 2019 were $1.275B, a 3.02% increase from 2018.
  • Haemonetics total assets for 2018 were $1.237B, a 0.11% decline from 2017.
  • Haemonetics total assets for 2017 were $1.239B, a 6.1% decline from 2016.
Haemonetics Annual Total Assets
(Millions of US $)
2019 $1,275
2018 $1,237
2017 $1,239
2016 $1,319
2015 $1,485
2014 $1,514
2013 $1,462
2012 $911
2011 $833
2010 $761
2009 $650
2008 $609
2007 $573
2006 $545
2005 $468
Haemonetics Quarterly Total Assets
(Millions of US $)
Q1 2019 $1,260
Q4 2019 $1,275
Q3 2018 $1,228
Q2 2018 $1,266
Q1 2018 $1,241
Q4 2018 $1,237
Q3 2017 $1,312
Q2 2017 $1,271
Q1 2017 $1,251
Q4 2017 $1,239
Q3 2016 $1,306
Q2 2016 $1,335
Q1 2016 $1,317
Q4 2016 $1,319
Q3 2015 $1,336
Q2 2015 $1,419
Q1 2015 $1,427
Q4 2015 $1,485
Q3 2014 $1,474
Q2 2014 $1,475
Q1 2014 $1,477
Q4 2014 $1,514
Q3 2013 $1,488
Q2 2013 $1,484
Q1 2013 $1,480
Q4 2013 $1,462
Q3 2012 $1,474
Q2 2012 $1,455
Q1 2012 $928
Q4 2012 $911
Q3 2011 $848
Q2 2011 $824
Q1 2011 $853
Q4 2011 $833
Q3 2010 $783
Q2 2010 $738
Q1 2010 $698
Q4 2010 $761
Q3 2009 $702
Q2 2009 $714
Q1 2009 $692
Q4 2009 $650
Q3 2008 $622
Q2 2008 $601
Q1 2008 $608
Q4 2008 $609
Q3 2007 $566
Q2 2007 $549
Q1 2007 $578
Q4 2007 $573
Q3 2006 $550
Q2 2006 $561
Q1 2006 $568
Q4 2006 $545
Q3 2005 $523
Q2 2005 $499
Q1 2005 $486
Q4 2005 $468
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.423B $0.968B
Haemonetics Corporation is a Global Leader in Blood Management Solutions. Their comprehensive portfolio of devices, information management, consulting services offers blood management solutions for each facet of the blood supply chain from plasma blood collectors to hospitals. They believe that through proper blood management, their portfolio of products and services helps to prevent a transfusion for the patient who doesn't need one and provides the right blood product, at the right time, in the right dose to the right patient who does.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $145.155B 20.38
Abbott Laboratories (ABT) United States $144.891B 27.24
Stryker (SYK) United States $80.414B 27.81
Boston Scientific (BSX) United States $53.574B 25.99
Baxter (BAX) United States $44.796B 27.16
EssilorLuxottica Societe Anonyme (ESLOY) France $32.784B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.311B 18.12
Coloplast (CLPBY) Denmark $25.596B 40.86
Lonza Group Ag (LZAGY) Switzerland $25.166B 0.00
Terumo (TRUMY) Japan $23.897B 29.82
Smith & Nephew SNATS (SNN) United Kingdom $20.556B 0.00
ResMed (RMD) United States $18.755B 35.74
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $9.968B 53.44
Insulet (PODD) United States $9.367B 555.07
Perrigo (PRGO) Ireland $7.321B 13.49
Canopy Growth (CGC) Canada $6.992B 0.00
Hill-Rom Holdings (HRC) United States $6.758B 20.15
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.322B 27.49
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.868B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.717B 0.00
Neogen (NEOG) United States $3.401B 56.90
NuVasive (NUVA) United States $3.312B 26.40
ICU Medical (ICUI) United States $3.149B 20.43
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.522B 0.00
Quidel (QDEL) United States $2.431B 24.14
Agios Pharmaceuticals (AGIO) United States $1.998B 0.00
National Vision Holdings (EYE) United States $1.919B 41.42
Cardiovascular Systems (CSII) United States $1.617B 0.00
Aphria (APHA) $1.368B 0.00
VAREX IMAGING (VREX) United States $1.117B 25.74
AtriCure (ATRC) United States $1.022B 0.00
Phibro Animal Health (PAHC) United States $0.885B 14.39
Eagle Pharmaceuticals (EGRX) United States $0.847B 21.60
NanoString Technologies (NSTG) United States $0.779B 0.00
PetIQ (PETQ) United States $0.778B 18.37
Omeros (OMER) United States $0.764B 0.00
Lantheus Holdings (LNTH) United States $0.742B 19.50
LeMaitre Vascular (LMAT) United States $0.670B 39.72
Cerus (CERS) United States $0.633B 0.00
Surmodics (SRDX) United States $0.607B 115.31
MacroGenics (MGNX) United States $0.562B 0.00
Quanterix (QTRX) United States $0.554B 0.00
OraSure Technologies (OSUR) United States $0.510B 23.60
TG Therapeutics (TGTX) United States $0.507B 0.00
Meridian Bioscience (VIVO) United States $0.423B 13.21
Owens & Minor (OMI) United States $0.406B 12.17
Zynex (ZYXI) United States $0.384B 40.79
Utah Medical Products (UTMD) United States $0.342B 25.05
BioLife Solutions (BLFS) United States $0.329B 101.06
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.321B 0.00
United Health Products (UEEC) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.223B 0.00
Vapotherm (VAPO) United States $0.179B 0.00
Rockwell Medical (RMTI) United States $0.153B 0.00
Cytosorbents (CTSO) United States $0.148B 0.00
Female Health (VERU) United States $0.137B 0.00
Fonar (FONR) United States $0.131B 9.16
InfuSystems Holdings (INFU) United States $0.129B 0.00
Liberty Health Sciences (LHSIF) $0.101B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
Chimerix (CMRX) United States $0.088B 0.00
United-Guardian (UG) United States $0.086B 20.46
Nephros (NEPH) United States $0.077B 0.00
MTech Acquisition (KERN) United States $0.063B 0.00
MRI Interventions (MRIC) United States $0.059B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Surface Oncology (SURF) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00